![]() NeuroTherapia NeuroTherapia is a company that develops a medical research platform intended to offer therapies to cure the neuroinflammation spectrum of diseases. | ![]() Invivyd Invivyd (also known as Invivyd Security) is a biopharmaceutical company that develops a platform for infectious viral disease treatment solutions. | ![]() Quince Therapeutics Italy Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells. | Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | ![]() NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. | |
Founding Date | Founding Date 2015 | Founding Date 2020 | Founding Date 2007 | Founding Date N/A | Founding Date 2015 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Gates Mills, US HQ | Locations HQ | Locations Bresso, IT HQ Tre Torri, IT | Locations New Haven, US HQ | Locations Beltsville, US HQ |
Employees | Employees 8 | Employees N/A | Employees 19 | Employees 13329% increase | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 108.3 m | Valuation ($) N/A | Valuation ($) 1.9 b | Valuation ($) 39.2 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($80.8m) (FY, 2025) | Net income ($55.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 11.5m | Total funding raised N/A | Total funding raised $ 35.6m | Total funding raised $ 111.6m | Total funding raised $ 160m |

Invivyd (also known as Invivyd Security) is a biopharmaceutical company that develops a platform for infectious viral disease treatment solutions.
View company
Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells.
View companyArvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View company
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View company